Actinic Keratosis Treatment Newly On Prescription
3/18/2012
A new topical gel now available by prescription significantly decreases the amount of time needed to treat actinic keratosis, a skin condition that is a common precursor to skin cancer, according to a multi-center trial led by researchers at Mount Sinai School of Medicine...
Breast Cancer Risk Related To Menopausal Hormone Therapy
3/18/2012
In the past decade, results from large prospective cohort studies and the Women's Health Initiative (WHI) randomized placebo-controlled hormone therapy trials have substantially changed thoughts about how estrogen alone and estrogen plus progestin influence the risk of breast cancer, according to a review published in the Journal of The National Cancer Institute...
Oral Cancer Drugs Not Effective When Mixed With Some Other Medications
3/17/2012
A study, which is being presented at the 2012 American Society for Clinical Pharmacology and Therapeutics (ASCPT) Annual Meeting, and conducted by the Medco Research Institute, claims that cancer drugs taken orally which hit enzymes in tumor cells may have been effective in the past for reducing the amount of time patients had to stay at centers to receive their chemotherapy,...
Surprising Connection Between Breast Cancer Cells And Surrounding Tissue
3/17/2012
Rensselaer Polytechnic Institute Biologist Lee Ligon has found a previously unknown connection between breast cancer tumor cells and the surrounding healthy tissue. The results provide new information on the earliest stages of breast cancer metastasis...
Leukemia Patients' Outcomes Predicted With Genetic Profiling
3/16/2012
According to a study due to be published in the March 22 issue of the New England Journal of Medicine, a set of genetic abnormalities in individuals with acute myelogenous leukemia (AML) have been identified by researchers at Memorial Sloan-Kettering Cancer Center...
HRT With Estrogen Added Raises Breast Cancer Risk
3/16/2012
According to a study published March 15 in the Journal of the National Cancer Institute, thoughts about how estrogen alone or estrogen in addition to progestin influence the risk of developing breast cancer has considerably changed in the past 10 years due to results from the Women's Health Initiative (WHI) randomized placebo-controlled hormone therapy trials, and from large p...
Obesity Increases The Risk For Colorectal Cancer And Polyps
3/16/2012
The American College of Gastroenterology (ACG) and the Campaign to End Obesity (CEO) are joining forces to highlight the potentially deadly link between higher Body Mass Index (BMI) and colorectal cancer...
Biomarker Links Clinical Outcome With New Model Of Lethal Tumor Metabolism
3/16/2012
Researchers at the Kimmel Cancer Center at Jefferson have demonstrated for the first time that the metabolic biomarker MCT4 directly links clinical outcomes with a new model of tumor metabolism that has patients "feeding" their cancer cells. Their findings were published online March 15 in Cell Cycle. To validate the prognostic value of the biomarker, a research team led by Agnieszka K...
Discovery Could Lead To Novel Drugs To Prevent Cancer Metastasis
3/16/2012
A Loyola University Chicago Stritch School of Medicine study has revealed details of the complex molecular process involving a protein that enables cancer cells to establish tumors in distant parts of the body. The finding could lead the way to new drugs to prevent breast cancer and other cancers from spreading to new sites...
Researchers have identified a set of genetic abnormalities in patients with acute myelogenous leukemia (AML) that doctors can use to more accurately predict patients' prognoses and select treatments that are most likely to benefit them. The study, led by investigators at Memorial Sloan-Kettering Cancer Center, will be published in the March 22 issue of the New England Journal of Medicine...